Key result
TJ-ICE-guided TAVR depth less than membranous septum length is linked to ~84% lower PPMI risk.
Why the study?
Data were limited on the impact of intracardiac echocardiography-guided TAVR on the rate of new permanent pacemaker implantation.
Does transjugular intracardiac echocardiography-guided TAVR reduce the incidence of new permanent pacemaker implantation in patients with severe aortic stenosis?
Observational (n=163)
Does transjugular intracardiac echocardiography-guided TAVR reduce the incidence of new permanent pacemaker implantation in patients with severe aortic stenosis?
Transjugular ICE-guided TAVR is feasible and allows for optimization of valve implantation depth relative to membranous septum length, significantly reducing the rate of new permanent pacemaker implantation.
Answers are grounded in this paper and cite their sources.
TJ-ICE-guided depth optimization was associated with lower PPMI; hypothesis-generating and requires randomized confirmation before practice change.
There are limited data on the impact of intracardiac echocardiography (ICE)–guided transcatheter aortic valve replacement (TAVR) on the new permanent pacemaker implantation (PPMI) rate. This study investigated the feasibility and outcome of transjugular ICE (TJ-ICE) –guided TAVR, by visualizing the relationship between the membranous septum (MS) and the transcatheter aortic valve (TAV). Among patients with severe aortic stenosis who underwent TAVR between February 2017 and June 2020, this study enrolled a total of 163 patients with TJ-ICE–guided TAVR. MS length was measured by ICE. The primary endpoint of this study was the incidence of new PPMI at 30 days. The mean age of the patients in this study was 84.9 ± 4.6 years, and 71.2% of the patients were female. Device success was 96.3% with TJ-ICE guidance. A TJ-ICE–related complication occurred in 1 case (0.6%). The median length of the MS was 5.8 mm (IQR: 5.0-6.9 mm). Excellent intraobserver (intraclass correlation coefficient [ICC]: 0.94; 95% CI:0.79-0.98; P < 0.001) and interobserver (ICC: 0.93; 95% CI: −0.05 to 0.98; P < 0.001) agreements were shown. The new PPMI rate was 6.7% at 30 days without a significant difference between balloon-expandable valves and self-expandable valves (3.4% vs 8.7%; P = 0.226). Patients with a TAV implantation depth less than MS length had a significantly lower incidence of new PPMI compared with patients with a TAV implantation depth greater than MS length (2.1% vs13.4%; P = 0.005), regardless of baseline right bundle branch block presence (6.7% vs 66.7%; P = 0.004) or absence (1.2% vs 8.2%; P = 0.041). TJ-ICE–guided TAVR demonstrated remarkable feasibility and safety. The TJ-ICE–guided final TAV position had a significant impact on the new PPMI rate. (Tokai Valve Registry; UMIN000036671)
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2023) conducted an observational in severe aortic stenosis (n=163). Transjugular intracardiac echocardiography (TJ-ICE)-guided TAVR was evaluated on incidence of new permanent pacemaker implantation (PPMI) at 30 days. TJ-ICE-guided TAVR with an implantation depth less than membranous septum length reduced new permanent pacemaker implantation compared to greater depth.
Synapse has enriched 10 related papers. Consider them for comparative context: